DrugPatentWatch Database Preview
Innogenix Company Profile
» See Plans and Pricing
What is the competitive landscape for INNOGENIX, and what generic and branded alternatives to INNOGENIX drugs are available?
INNOGENIX has five approved drugs.
Summary for Innogenix
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Innogenix
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Innogenix | METRONIDAZOLE | metronidazole | TABLET;ORAL | 070772-002 | Jul 16, 1986 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Innogenix | BACLOFEN | baclofen | TABLET;ORAL | 212378-002 | Oct 9, 2020 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Innogenix | HALOPERIDOL | haloperidol | TABLET;ORAL | 071173-003 | Jan 2, 1987 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Innogenix | LABETALOL HYDROCHLORIDE | labetalol hydrochloride | TABLET;ORAL | 075215-002 | Jul 29, 1999 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
